The autoinjector is based on core technology licensed from Bespak. UCB announced that EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended the use of Cimzia (certolizumab pegol) ...

UCB says it has launched in the UK a new pre-filled self-injecting device for its anti-inflammatory drug Cimzia that was designed in collaboration with patients. UCB says it has launched in the UK a ...

Please provide your email address to receive an email when new articles are posted on . Following a positive opinion by a European Medicine Agency committee, the certolizumab pegol autoclicks ...

Rheumatoid arthritis (RA) is a type of arthritis that is considered an autoimmune disease. An autoimmune disease is when your immune system starts attacking your body. It causes pain and swelling in ...

The Food and Drug Administration (FDA) has approved Cimzia to treat certain inflammatory conditions in adults, including rheumatoid arthritis. It’s also FDA approved for polyarticular juvenile ...

Cimzia (certolizumab) is a prescription drug used to treat plaque psoriasis, Crohn’s disease, and some types of arthritis, including rheumatoid arthritis. It’s given as an injection under the skin.

Consort Medical plc ("Consort Medical", "Consort" or the "Group") (LSE: CSRT), notes the announcement from UCB, dated 26 October 2016, that the new certolizumab pegol (Cimzia®) AutoClicks® prefilled ...

A self-injection pen prefilled with Brussels-based UCB’s Cimzia (certolizumab pegol) has been made available this week in the U.K. after a positive opinion from the EMA. UCB developed the AutoClicks ...

Each of these conditions causes your immune system (the body’s defense against disease) to mistakenly attack healthy cells. Cimzia and Humira help prevent the immune system from doing this. The drugs ...

UCB says it has launched in the UK a new pre-filled self-injecting device for its anti-inflammatory drug Cimzia that was designed in collaboration with patients. UCB says it has launched in the UK a ...